Home » Clinical Trials » Therapeutic Areas

Therapeutic Areas: Neurology
Disease Category: Neurologic Disorders
Location: United States, NY

Clinical Trial Details


Research Study Summary

Clinical Studies of Patients with Paraneoplastic Neurologic Disorders


We are studying patients with paraneoplastic neurologic disorders (The Hu syndrome, a.k.a. Paraneoplastic Subacute Sensory Neuropathy/Encephalomyelitis or Limbic Encephalopathy, and The Ri Syndrome, a.k.a. Paraneoplastic Opsoclonus-Myoclonus Ataxia) in two IRB-approved protocols at the Rockefeller University Clinical Research Center. One study is aimed at furthering our understanding of the cause of these disorders, and a second is a treatment protocol based on our laboratory studies.

All patients with paraneoplastic neurologic disorders are eligible, including patients with:

  • Paraneoplastic Cerebellar Degeneration
  • The Hu Syndrome
    • Paraneoplastic Subacute Sensory Neuropathy/Encephalomyelitis
    • Limbic Encephalopathy
  • Paraneoplastic Opsoclonus-Myoclonus Ataxia (The Ri Syndrome)
To Learn more

CW ID: 23171
Date Last Changed: July 25, 2013

Clinical Trial Snapshot

Both Male and Female
Overall Status
Facility Type


Mayu Frank
The Rockefeller University Hospital
1230 York Avenue
New York, NY 10021-6399
Phone: 212-327-7443

View Map

Research Center Information:

The Rockefeller University Hospital

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.